Linear IgA bullous dermatosis. An immunologically defined disease

Area of Science:

• Dermatology
• Immunodermatology
• Autoimmune Blistering Diseases

Background:

• Linear IgA bullous dermatosis (LABD) presents clinical and histological similarities to bullous pemphigoid (BP) and dermatitis herpetiformis (DH).
• Accurate differentiation is crucial for appropriate patient management and therapeutic strategies.

Purpose of the Study:

• To compare demographic, clinical, and immunopathological features of LABD with BP, DH, and cicatricial pemphigoid (CP).
• To highlight the diagnostic utility of direct immunofluorescence in distinguishing LABD.

Main Methods:

• Retrospective analysis of 234 BP, 27 LABD, 60 DH, and 20 CP cases.
• Evaluation of patient demographics, histological findings, and direct immunofluorescence results, focusing on IgA and C3 deposition at the basement membrane zone (BMZ).

Main Results:

• BP patients were significantly older than LABD and DH patients; LABD patients were older than DH patients.
• BP and CP showed a higher female predilection (65-70%) compared to LABD and DH (44-48%).
• C3 deposition at the BMZ was significantly more frequent in BP (85%) than in LABD (18.5%) and DH (28.3%). Direct immunofluorescence confirmed linear IgA deposition in LABD.

Conclusions:

• Direct immunofluorescence is the gold standard for diagnosing LABD by detecting linear IgA deposits at the BMZ.
• LABD exhibits distinct demographic and immunopathological profiles compared to BP and DH.
• Treatment responses in LABD varied, with some patients benefiting from corticosteroids, sulfones, or a combination therapy.